Business Description
Namwiwat Medical Corp PCL
ISIN : THB663010007
Description
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.44 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 2.47 | |||||
Interest Coverage | 4.79 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.26 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.4 | |||||
3-Year EBITDA Growth Rate | -1.6 | |||||
3-Year EPS without NRI Growth Rate | -16.3 | |||||
3-Year FCF Growth Rate | 44.4 | |||||
3-Year Book Growth Rate | 18.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.2 | |||||
9-Day RSI | 46.34 | |||||
14-Day RSI | 43.98 | |||||
3-1 Month Momentum % | -3.8 | |||||
6-1 Month Momentum % | 1.14 | |||||
12-1 Month Momentum % | -17.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.49 | |||||
Quick Ratio | 2.28 | |||||
Cash Ratio | 1.16 | |||||
Days Inventory | 227.36 | |||||
Days Sales Outstanding | 127.45 | |||||
Days Payable | 66.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.76 | |||||
Dividend Payout Ratio | 1.3 | |||||
Forward Dividend Yield % | 8.09 | |||||
5-Year Yield-on-Cost % | 3.78 | |||||
Shareholder Yield % | -2.85 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.96 | |||||
Operating Margin % | 5.81 | |||||
Net Margin % | 4.54 | |||||
EBITDA Margin % | 11.21 | |||||
FCF Margin % | -3.81 | |||||
OCF Margin % | 0.22 | |||||
ROE % | 3.81 | |||||
ROA % | 2.56 | |||||
ROIC % | 4.22 | |||||
3-Year ROIIC % | -6.18 | |||||
ROC (Joel Greenblatt) % | 7.05 | |||||
ROCE % | 4.93 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 33.01 | |||||
Forward PE Ratio | 8.87 | |||||
PE Ratio without NRI | 34 | |||||
PS Ratio | 1.4 | |||||
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.29 | |||||
Price-to-Operating-Cash-Flow | 680 | |||||
EV-to-EBIT | 20.09 | |||||
EV-to-EBITDA | 12.08 | |||||
EV-to-Revenue | 1.36 | |||||
EV-to-FCF | -35.33 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Graham-Number | 1.4 | |||||
| Price-to-Net-Current-Asset-Value | 2.04 | |||||
Earnings Yield (Greenblatt) % | 4.98 | |||||
FCF Yield % | -2.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Namwiwat Medical Corp PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 1,708.549 | ||
| EPS (TTM) (฿) | 0.103 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 13.16 | ||
| 14-Day RSI | 43.98 | ||
| 14-Day ATR (฿) | 0.05422 | ||
| 20-Day SMA (฿) | 3.493 | ||
| 12-1 Month Momentum % | -17.67 | ||
| 52-Week Range (฿) | 3.2 - 4.4 | ||
| Shares Outstanding (Mil) | 700 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Namwiwat Medical Corp PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Namwiwat Medical Corp PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.030000 Cash Dividend | 2026-03-13 | 3.80 (+2.15%) | ||
| THB 0.100000 Cash Dividend | 2025-11-27 | 3.76 (+1.08%) | ||
| THB 0.150000 Cash Dividend | 2025-03-14 | 4.22 (-1.40%) |
Show
Entries
Namwiwat Medical Corp PCL Frequently Asked Questions
What is Namwiwat Medical Corp PCL(BKK:NAM)'s stock price today?
The current price of BKK:NAM is ฿3.40. The 52 week high of BKK:NAM is ฿4.40 and 52 week low is ฿3.20.
When is next earnings date of Namwiwat Medical Corp PCL(BKK:NAM)?
The next earnings date of Namwiwat Medical Corp PCL(BKK:NAM) is .
Does Namwiwat Medical Corp PCL(BKK:NAM) pay dividends? If so, how much?
The Dividend Yield %  of Namwiwat Medical Corp PCL(BKK:NAM) is 3.76% (As of Today), Highest Dividend Payout Ratio of Namwiwat Medical Corp PCL(BKK:NAM) was 1.76. The lowest was 0.37. And the median was 1.06. The  Forward Dividend Yield % of Namwiwat Medical Corp PCL(BKK:NAM) is 8.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Namwiwat Medical Corp PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers